Adaptive NK cells in people exposed to Plasmodium falciparum correlate with protection from malaria by Hart, Geoffrey T. et al.
BRIEF DEFINITIVE REPORT
Adaptive NK cells in people exposed to Plasmodium
falciparum correlate with protection from malaria
Geoffrey T. Hart1,2, Tuan M. Tran3*, Jakob Theorell4*, Heinrich Schlums4, Gunjan Arora1, Sumati Rajagopalan1, A.D. Jules Sangala1,2,
Kerry J. Welsh5, Boubacar Traore6, Susan K. Pierce1, Peter D. Crompton1, Yenan T. Bryceson4, and Eric O. Long1
How antibodies naturally acquired during Plasmodium falciparum infection provide clinical immunity to blood-stage malaria is
unclear. We studied the function of natural killer (NK) cells in people living in a malaria-endemic region of Mali. Multi-
parameter flow cytometry revealed a high proportion of adaptive NK cells, which are defined by the loss of transcription
factor PLZF and Fc receptor γ-chain. Adaptive NK cells dominated antibody-dependent cellular cytotoxicity responses, and
their frequency within total NK cells correlated with lower parasitemia and resistance to malaria. P. falciparum–infected RBCs
induced NK cell degranulation after addition of plasma from malaria-resistant individuals. Malaria-susceptible subjects with
the largest increase in PLZF-negative NK cells during the transmission season had improved odds of resistance during the
subsequent season. Thus, antibody-dependent lysis of P. falciparum–infected RBCs by NK cells may be a mechanism of acquired
immunity to malaria. Consideration of antibody-dependent NK cell responses to P. falciparum antigens is therefore warranted
in the design of malaria vaccines.
Introduction
Natural sterile immunity to Plasmodium falciparum is rarely if
ever acquired even after years of chronic exposure (Tran et al.,
2013). If sterile immunity is not achieved in the liver, vaccine
recipients remain fully susceptible to the disease caused by
blood-stage malaria. In malaria-endemic areas, clinical immu-
nity develops over years of repeated infections and manifests as
reduced blood-stage parasite load (parasitemia) and control of
inflammatory responses (Portugal et al., 2017b). Antibodies to
malaria antigens, which are essential for protection (Cohen
et al., 1961; Crompton et al., 2014), may neutralize P. falcipa-
rum merozoites (Rotman et al., 1998), activate complement-
mediated lysis of merozoites (Boyle et al., 2015), or trigger im-
mune responses through Fc receptors. Antibodies to P. falcipa-
rum antigens expressed on infected RBCs trigger phagocytosis
by monocytes (Khusmith and Druilhe, 1983) and antibody-
dependent cellular cytotoxicity (ADCC) by natural killer (NK)
cells (Arora et al., 2018). The potential of NK cell–mediated
ADCC to protect individuals against malaria has not been ex-
amined (Wolf et al., 2017). The aim of this study was to evaluate
phenotypic and functional attributes of NK cells in people
naturally exposed to P. falciparum and examine whether any
parameter correlated with protection against P. falciparum
infection.
Human peripheral blood NK cells are divided into a larger
subset of CD56dim cells and a smaller subset of CD56bright
(CD56bri) cells that do not express FcγRIIIa (CD16) and lack
ADCC activity. Recently, so-called “adaptive” NK cells with en-
hanced ADCC activity were described in CMV-infected in-
dividuals (Sun et al., 2009; Lopez-Vergès et al., 2011; Lee et al.,
2015; Schlums et al., 2015). Adaptive NK cells are broadly de-
fined as CD56dim cells that have lost expression of transcription
factor promyelocytic leukemia zinc finger (PLZF) and of the
signaling Fc receptor γ-chain (FcRγ) through epigenetic changes
(Tesi et al., 2016). PLZF− FcRγ−NK cells that expand during CMV
infection express NKG2C, an activating receptor that binds to
HLA-E, including HLA-E loaded with CMV-derived peptides
(Holmes and Bryceson, 2016; Hammer et al., 2018). Information
about adaptive NK cells in other diseases is very limited.
A longitudinal cohort study of malaria immunity in children
and young adults was started in 2011 in Kalifabougou, Mali,
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where rainy seasons with intense P. falciparum malaria trans-
mission predictably alternate with dry seasons during which
malaria rarely occurs (Doumbo et al., 2014). Within this cohort,
we found that the relative abundance of PLZF− FcRγ− NK cells
correlated with decreased parasitemia and prospectively pre-
dicted protection from malaria symptoms. These adaptive NK
cells had enhanced cytokine production and cytotoxic activity
in response to antibody-dependent activation. As NK cells of
study subjects were activated by P. falciparum–infected RBCs
in the presence of plasma from malaria-resistant individuals,
these findings support a functional contribution of NK cells
to protection from malaria through enhanced ADCC toward
P. falciparum–infected RBCs.
Results and discussion
High frequency of PLZF− FcRγ− NK cells in a cohort of
malaria-exposed individuals
Peripheral blood mononuclear cells (PBMCs) from 163 subjects
2–22 yr of age (Fig. 1 A and Fig. S1 A) were collected before and
after the malaria transmission season, which occurred between
June and December 2013 (Fig. 1 B). In addition, PBMCs were
collected from susceptible subjects at their first clinical malaria
episode and again 7 d after treatment with artemether and lu-
mefantrine. Approximately half of the subjects suffered at least
one malaria episode during the transmission season (Fig. 1 C). A
multi-parameter flow cytometry analysis of all samples collected
in May showed that CD56bri NK cells constituted ∼10% of total
NK cells (Fig. 1 D) with the expected CD57− NKG2A+ phenotype
(Fig. 1 E). CD56dim NK cells had a high proportion of PLZF−
(∼70%) and FcRγ− (∼40%) cells (Fig. 1 F), reminiscent of adaptive
NK cells observed during CMV infection (Schlums et al., 2015).
An aggregate of primary flow data for all subjects showed that
CD56bri NK cells had intermediate fluorescence signals for FcRγ
and Eat-2 and brighter signals for CD2, NKG2A, and Syk
(Fig. 1 G). In this population of subjects as a whole (but not
necessarily for every subject), CD56dim NK cells were bimodal
for every marker tested (Fig. 1 G). The complexity of phenotypic
subsets was illustrated by t-distributed stochastic neighbor
embedding (t-SNE) plots (Fig. 1 H).
A direct comparison with NK phenotypic subsets in PBMCs
of 18 Swedish adults, which were included in our analysis of
Mali samples, showed that the major subsets enriched in Ma-
lian subjects share a CD57+ NKG2A− PLZF− FcRγ− phenotype
(Fig. S1 B).
Most plasma samples from Malian subjects were positive for
antibodies to EBV and CMV, consistent with early seroconver-
sion to EBV and CMV in African children (Manicklal et al., 2013;
Bates and Brantsaeter, 2016). Phenotypic subsets of NK cells in
the 12 EBV− subjects did not differ significantly from EBV+
subjects (Fig. S1, C and D). CMV infection, which has a major
impact on the human immune system (Brodin et al., 2015) and
drives expansion of adaptive NK cells (Schlums et al., 2015), is
likely to have contributed to the expansion of FcRγ− NK cells in
the Mali cohort. As expected (Lopez-Vergès et al., 2011; Schlums
et al., 2015), the 10 CMV− subjects had a lower proportion of
NKG2C+ and higher proportion of NKG2A+ NK cells (Fig. S1 E).
However, the CMV− subjects had a frequency of FcRγ− NK cells
similar to that of CMV+ subjects (Fig. S1 E), suggesting that FcRγ−
NK cells increase also in response to other stimuli.
Adaptive FcRγ− NK cells during CMV infection are mostly
CD57+ NKG2C+ (Lopez-Vergès et al., 2011; Foley et al., 2012). In
Malian subjects, however, FcRγ− NK cells included a higher
proportion of CD57− NKG2C− NK cells than CD57+ NKG2C+ NK
cells (Fig. S1 F), suggesting a greater diversity of adaptive NK
cells in the Mali cohort.
Correlation of FcRγ− NK cells with parameters of malaria
Resistance to malaria disease was monitored in two ways. One
was to compare individuals who did not experience clinical
symptoms (resistant) to those who had at least one episode of
febrile malaria (susceptible; Fig. 1 A). The other measured the
time elapsed from the beginning of the malaria transmission
season to the first episode of febrile malaria (Fig. 1 C). A higher
frequency of FcRγ− NK cells was significantly associated with
disease resistance (Fig. 2 A). It follows that conventional FcRγ+
NK cells were associated with sensitivity to malaria. Analysis of
all NK cell subsets with single, double, and triple combinations
of six markers (CD2, CD57, NKG2C, NKG2A, FcRγ, and PLZF)
showed that those most significantly associated with resistance
were FcRγ− PLZF− and FcRγ− NK cells (P < 0.0024; Fig. S2 A).
Furthermore, subjects with the highest proportion of FcRγ− NK
cells before the malaria season experienced a significantly lon-
ger delay until the first malaria episode (Fig. 2 B). Comparison of
all subsets with single, double, and triple combinations of the
same six phenotypic markers revealed that enrichment of CD57−
FcRγ− PLZF− or total FcRγ− NK cells had the most significant
association with delayed onset of malaria (P < 0.0029; Fig. S2 B).
Therefore, by two different criteria—resistance to malaria
symptoms and delayed onset of disease—a higher frequency of
FcRγ− NK cells in May correlated with protection from malaria
symptoms during the ensuing transmission season.
Among susceptible subjects, parasite load during acute ma-
laria was inversely correlated with frequency of FcRγ− and PLZF−
NK cells (Fig. 2 C). Resistant subjects had a significantly higher
frequency of FcRγ− and PLZF− NK cells than those with a high
parasite load during malaria (Fig. 2 D). Among multiple combi-
nations of phenotypic markers, the FcRγ− PLZF− double-negative
and FcRγ− NK cells were the most significantly associated with
resistance (P < 0.0001; Fig. S2 C). Among all phenotypic markers
tested, FcRγ− was the only one strongly associated with every
measure of resistance: reduced parasite load, increased proba-
bility of remaining disease-free, and delayed disease onset during
the transmission season.
An essential component to malaria disease resistance is an-
tibodies to P. falciparum antigens (Bustamante et al., 2017).
Chronic exposure to P. falciparum infection leads to the pro-
duction of atypical memory B cells, which fail to generate
functionally mature memory B cells and long-lived plasma cells
(Portugal et al., 2017a). As it takes years of repeated infections to
acquire antibodies that provide clinical immunity, age is sig-
nificantly correlated with resistance to malaria symptoms
(Crompton et al., 2014) and inversely correlated with parasite
load, as observed in our cohort (P = 0.004; Fig. S2 D). Increased
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Figure 1. NK cell phenotype ofMalian subjects. (A) Number of resistant and susceptible subjects in different age groups. (B) Incidence of malaria during the
transmission season. (C) Probability of developing malaria symptoms during the transmission season. (D–F) Frequency of CD56bri NK cells among total NK cells
(D) and of each indicated marker on CD56bri (E) and CD56dim (F) NK cells. Mean average is shown as a red bar. (G) Combined flow cytometry data files from all
subjects at the May time point showing expression of phenotypic markers against CD56 expression. (H) t-SNE analysis of NK cell subsets for all subjects at the
May time point. Expression of each marker is indicated by a color scale. Flow cytometry data in D–H was acquired over 15 independent experiments (n = 163).
Each experiment included internal controls described in the Materials and methods section.
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Figure 2. Correlation of FcRγ− and PLZF− NK cell frequency with protection against malaria. (A) Frequency of FcRγ− (left) and PLZF− (right) NK cells in
susceptible and resistant subjects. Unpaired Student’s t tests, ***, P < 0.001; *, P < 0.05. (B) Time to first malaria episode in subjects separated into the top
tercile with the highest frequency of FcRγ− (left) or PLZF− (right) NK cells and all other subjects. P values determined with log rank Mantel–Cox test. (C)
Frequency of FcRγ− (left) and PLZF− (right) NK cells versus parasite density (parasites/µl) on a log scale. R2 goodness-of-fit analysis on nonlinear regression line
is shown. P values determined by Pearson correlation. p, parasites. (D) Frequency of FcRγ− (left) and PLZF− (right) NK cells in resistant subjects (no malaria)
compared with subjects ranked in terciles with low, medium (Med), or high parasite load. One-way ANOVA was done with post hoc test comparing low,
medium, and high groups to the no malaria group only. ***, P < 0.001; **, P < 0.01; *, P < 0.05. (E) Frequency of FcRγ− (left) and PLZF− (right) NK cells in
subjects ranked by age. R2 and P values determined as in C. (F) Frequency of FcRγ− (left) and PLZF− (right) NK cells versus frequency of FcRγ− PLZF− double-
negative NK cells. R2 and P values determined as in C. (G) Frequency of FcRγ− (left) and PLZF− (right) NK cells at the first malaria episode compared with their
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frequency of FcRγ− NK cells was significantly associated with
age, showing a large transition at ∼8 yr of age (Fig. 2 E). In
contrast, the frequency of PLZF−NK cells had a wide distribution
(∼20% to ∼80%) among young individuals, which gradually
converged to a higher frequency with age (Fig. 2 E). A multiple
linear regression model suggested a negative association of age
with parasite load after adjustment for frequency of FcRγ− NK
cells (P = 0.035) or PLZF− NK cells (P = 0.012; Fig. S2 E). The
frequency of PLZF−NK cells on its own, after adjustment for age,
showed an inverse correlation with parasitemia (P = 0.044; Fig.
S2 E). Overall, these results suggest that adaptive FcRγ− PLZF− NK
cells contribute to protection against malaria.
Association of PLZF− NK cells with protection against future
malaria episodes
Loss of PLZF expression is thought to be a precursor to epige-
netic changes that turn off several genes, including the FCER1G
gene for FcRγ (Schlums et al., 2015; Tesi et al., 2016). Accord-
ingly,Malian subjects had virtually no PLZF+ FcRγ−NK cells, and
most subjects had a large proportion of FcRγ+ cells in the PLZF−
subset (Fig. 2 F). Therefore, individuals with a high proportion
of PLZF− FcRγ+ NK cells may be poised to increase the size of
their PLZF− FcRγ− cell subset.
Having shown that the frequency of FcRγ− NK cells in May,
before the transmission season, was significantly associated
with resistance to malaria symptoms later, during the trans-
mission season, we then asked whether an increase in FcRγ− or
PLZF− NK cell frequency in susceptible subjects during the
transmission season would predict protection during malaria
season in the following year (2014). The 10 subjects with the
largest relative increase in FcRγ− or PLZF− NK cell frequency
between May 2013 and the first clinical malaria episode
(Fig. 2 G) did not fare significantly better in 2014 (Fig. 2 H).
However, the 10 subjects with the largest increase in PLZF− NK
cells, but not FcRγ− NK cells, between May and December 2013
(Fig. 2 I) had a significantly greater probability of remaining
disease-free during the following year (Fig. 2 J). This would
represent an age-independent contribution of PLZF− NK cells to
protection, since within-subject changes in NK subset frequen-
cies were used to assess differences in resistance to malaria
during the subsequent year. It also supports the hypothesis that
PLZF− FcRγ+ NK cells are the critical pool from which FcRγ− NK
cells arise.
Antibody-dependent NK cell responses are largely confined to
FcRγ− NK cells
The functionality of NK cells from all subjects was tested for
their innate response to the HLA class I–negative tumor cell
line 721.221 and for their activation by CD16 in an ADCC assay.
To compare the contribution of different NK cell phenotypic
subsets to functional responses, we performed a t-SNE analysis
of the overlay of all phenotypic markers included in functional
assays (Fig. 3 A). Next, a computational analysis was performed
to determine the probability NK cells in different phenotypic
subsets had to produce IFN-γ or degranulate in response to ac-
tivation during natural cytotoxicity or ADCC (Fig. 3 B).
A large fraction of NK cells responded in the natural cyto-
toxicity assay, withmultiple subsets having a good probability to
produce IFN-γ and to degranulate (Fig. 3, A and B). Notably, the
presence or absence of FcRγ in NK cells had little impact on the
overall probability for response to 721.221 cells (Fig. 3, A and B).
More specialized subsets were CD57–NKG2C–NKG2A+ FcRγ+ NK
cells for degranulation, and CD57+ NKG2C+ NKG2A− FcRγ+ NK
cells for IFN-γ (Fig. 3, A and B). IFN-γ expressing CD56bri
NK cells were also enriched in the NKG2C+ subset (Fig. 3, A–C).
As expected, CD56bri NK cells, which do not express CD16, did
not respond in the ADCC assay (Fig. 3, A and B).
In marked contrast with the broad distribution of NK cells
stimulated during natural cytotoxicity, functional responses in
the ADCC assay were largely confined to the FcRγ− NK cell
subset (Fig. 3, A, B, and D). Conventional FcRγ+ NK cells re-
sponded poorly in the ADCC assay, despite good functionality in
the natural cytotoxicity assay, suggesting that FcRγ+ NK cells
have diminished ADCC responses during malaria. Enhanced
cytokine production by FcRγ− NK cells stimulated by CD16 oc-
curred in CMV-induced adaptive NK cells (Lee et al., 2015;
Schlums et al., 2015) and NK cells in HIV-infected individuals
(Zhou et al., 2015). In our Mali cohort, NKG2A− FcRγ− NK cells
dominated both the IFN-γ and the CD107a responses during
ADCC (Fig. 3, A, B, and D). While CD57– NKG2C– NKG2A– FcRγ−
NK cells were more prone to degranulate (Fig. 3, A and B), CD57+
NKG2C+ NK cells were those enriched in the pool of IFN-γ+ NK
cells, as observed also in the natural cytotoxicity assay (Fig. 3 E).
A polyfunctional subset of NK cells, capable of responding
during natural cytotoxicity and ADCC for IFN-γ production and
degranulation, was identified as NKG2C+ NKG2A− FcRγ− (Fig. 3,
A and B). The basis for the enrichment of NKG2A− cells within
responding cells triggered by CD16 (Fig. 3 D) is unclear. Perhaps
licensing of NK cells through inhibitory killer-cell Ig-like re-
ceptors, which dominates in the absence of strong ligands for
NKG2A (Horowitz et al., 2016), improves the ADCC response of
NK cells from subjects in the Mali cohort. Genetic associa-
tion studies on a larger cohort would be required to test this
hypothesis.
As with every other phenotypic marker on CD56dim NK cells
(Fig. 1 G), CD16 expression was bimodal, with a wide range of
CD16+ NK cell frequency among subjects (Fig. S3, A–C). CD16+
NK cell frequency showed no correlation with susceptibility to
malaria (Fig. S3 D). CD16− CD56dim cells can arise from
activation-induced CD16 downmodulation (Jing et al., 2015).
frequency in May. Red dots indicate the 10 subjects with the highest relative increase between May and malaria episode. (H) Time to first malaria episode
during the 2014 transmission season. The top 10 subjects listed in G are shown in red. P values determined with log rank Mantel–Cox test. (I) Frequency of
FcRγ− (left) and PLZF− (right) NK cells in December 2013 compared with their frequency in May, displayed as in G. (J) Time to first malaria episode during the
2014 transmission season, displayed as in H. P values determinedwith log rankMantel–Cox test. Flow cytometry data in A, C–F, and I were acquired as in Fig. 1.
Neg., negative.
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Indeed, most NK cells that were activated to degranulate and to
produce IFN-γ were CD16− after stimulation (Fig. S3 E).
In chronic HIV-1 infection, the frequency of CD8+ NK cells is
associated with a delay in disease progression (Ahmad et al.,
2014). In our Mali cohort, CD8+ NK cell subsets showed no
particular affiliation with other phenotypic markers or func-
tional responses (Fig. 3, A and B).
The main conclusion from this functional analysis is that NK
cell responses to Ab-coated target cells were largely confined to
the FcRγ− NK cell subset. Furthermore, phenotypic NK cell
subsets with the most significant enrichment in resistant sub-
jects were also the strongest responders to CD16-induced de-
granulation. Resistant subjects compared with subjects with a
high parasite load, and susceptible subjects with the longest
Figure 3. Contribution of NK cell phenotypic subsets to functional responses. (A) t-SNE analysis of NK cell phenotypic subsets in functional assays,
combining controls (in the absence of target cells), natural cytotoxicity, and ADCC assays for all subjects at the May time point. A color scale indicates ex-
pression level. (B) Delta probability of IFN-γ production and degranulation (CD107a) by NK cells stimulated in natural cytotoxicity (NC, left) and ADCC (right)
assays. This probability, determined computationally and shown as a color scale, was overlaid on the same t-SNE distribution shown in A in order to identify
specific phenotypic NK cell subsets that contributed to functional responses. The probability of a response in unstimulated controls was subtracted.
(C) Frequency of NKG2C+ NK cells among CD56bri NK cells for each subject (black dots), and among CD56bri NK cells that produced IFN-γ or degranulated
(CD107a) in the natural cytotoxicity assay (blue dots). One-way ANOVA with post hoc test comparing the responding cell frequency (blue) only to abundance
(black). ****, P < 0.0001; ***, P < 0.001; *, P < 0.05. (D) Analysis performed as in C for NKG2A+ and FcRγ− NK cells among CD56dim NK cells (black) and among
CD56dim NK cells that responded in natural cytotoxicity and ADCC assays. (E) Analysis performed as in D for CD57− NKG2C− and CD57+ NKG2C+ NK cells. For
C–E, one-way ANOVAwith post hoc test comparing the responding cell frequency (blue) only to abundance (black). ****, P < 0.0001; ***, P < 0.001; *, P < 0.05.
Flow cytometry data in A and C–E were acquired as in Fig. 1.
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delay to first malaria episode, had significantly higher pro-
portions of CD57− FcRγ−NK cells (Fig. S2). The highest probability
of degranulation in response to CD16 was in the NKG2A− FcRγ−
subset of NK cells (Fig. 3, A, B, and D). The strong degranulation
potential of FcRγ− NK cells in Mali subjects could result in lysis of
infected RBCs through ADCC, thereby reducing parasitemia and
contributing to clinical immunity to malaria.
Elevated degranulation potential of CD56dim NK cells during
malaria episodes
The number of NK cells per unit of blood did not vary signifi-
cantly from before (May) to after (December) the malaria
transmission season (Fig. 4 A). The proportion of CD56dim NK
cells among lymphocytes decreased during episodes of febrile
malaria, and recovered 7 d after anti-malaria treatment (Fig. 4
A). In contrast, the proportion of CD56bri NK cells among lym-
phocytes increased 7 d after treatment (Fig. 4 A). The opposite
relative changes in CD56dim and CD56bri NK cell abundance
suggest they were not caused by large fluctuations in total
lymphocyte numbers. Such rapid changes could be due to NK
cell adhesion in the vasculature or homing to peripheral tissue
during acute infection. IFN-γ responses stimulated by natural
cytotoxicity and ADCC did not change longitudinally (Fig. 4, B
and C). In contrast, a significantly higher proportion of CD56dim
NK cells degranulated during acute malaria relative to prema-
laria season samples (Fig. 4, B and C). As resistance to malaria
symptoms requires control of parasite load and of the associated
inflammatory response, the selective increase in degranulation
without increase in IFN-γ production may contribute to pro-
tection by limiting inflammation. Anti-inflammatory responses
required to reduce fever during malaria may include production
of IL-10 by CD4 T cells (Portugal et al., 2017b) and by human NK
cells stimulated with IL-15 (Burrack et al., 2018).
Figure 4. Longitudinal analysis of NK cells during the malaria season
and NK cell degranulation in response to P. falciparum–infected RBCs.
(A) CD56bri (top panels) and CD56dim (lower panels) NK cell number per
microliter at the May and December time points (left panels) and NK cell
frequency among total lymphocytes (right panels) at the four time points in
May, at the first malaria episode (Mal.), 7 d after treatment (Post-Rx), and in
December (Dec.). For cell numbers, an unpaired t test was used. For cell
frequency, one-way ANOVA with post hoc test was performed comparing
malaria episode, Post-Rx, or December to the May time point only. ***, P <
0.001. (B) Functional responses of CD56bri (top panels) and CD56dim (lower
panels) NK cells for IFN-γ production (left panels) and degranulation (right
panels) in the natural cytotoxicity assay. One-way ANOVA with post hoc test
comparing malaria episode, Post-Rx, or December only to the May time point.
***, P < 0.001; **, P < 0.001; *, P < 0.05. (C) Functional response of CD56dim
NK cells in the ADCC assay across longitudinal time points. One-way ANOVA
with post hoc test comparing malaria, Post-Rx, or December to the May time
point only. ****, P < 0.0001. (D) PBMCs of 30 Malian subjects were tested for
CD56dim NK cell degranulation in response to P. falciparum–infected RBC. The
ADCC assay (P815 + anti-mouse CD32) used in Fig. 3 was performed here for
comparison. PBMCs were incubated in the absence (–) or presence of RBC
and of P. falciparum–infected RBC (iRBC), as indicated. Serum from US adults
(US) and plasma from Mali adults were added, as indicated. One-way ANOVA
was done with post hoc analysis comparing each group with the NK cell only
control. ****, P < 0.0001; **, P < 0.01. (E) FcRγ− NK cell frequency among
CD56dim NK cells (black symbols) and among CD107a+ CD56dim NK cells
stimulated by iRBC in the presence of Mali plasma (blue symbols). A paired
t test was performed. ****, P < 0.0001. Flow cytometry data in A–C were
acquired as in Fig. 1. Flow cytometry data in D and E were acquired over three
independent experiments (n = 30).
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Activation of FcRγ− NK cells by P. falciparum–infected RBCs
and plasma of malaria-immune individuals
We tested the ability of NK cells in 30 PBMC samples from
Malian subjects to respond to P. falciparum–infected RBCs. NK
cell natural cytotoxicity degranulation in the presence of in-
fected RBCs was no higher than basal degranulation observed in
the presence or absence of uninfected RBCs (Fig. 4 D). In con-
trast, addition of plasma from malaria-resistant Mali adults, but
not healthy US adults, to infected RBCs triggered ADCC de-
granulation by NK cells (Fig. 4 D). Notably, degranulation was
considerably higher than that obtained in the generic ADCC
assay used to screen samples from the larger cohort (Fig. 4 D).
Furthermore, FcRγ− cells were significantly enriched in the pool
of degranulating NK cells (Fig. 4 E). As NK cells from US donors
were capable of lysing P. falciparum–infected RBCs through an Fc
receptor–dependent activation by IgG antibodies, and in the
presence of the sameMali plasma sample used here (Arora et al.,
2018), individuals in the Mali cohort, many of whom have a
large proportion of FcRγ− NK cells, are well equipped to elimi-
nate infected RBCs through ADCC by NK cells. These results, and
the high-frequency FcRγ− NK cell association with disease re-
sistance, demonstrated a strong potential of adaptive FcRγ− NK
cells to execute antibody-dependent control of malaria.
Implications
Control of infectious disease through NK-mediated ADCC is an
emerging theme, as a large study of Mycobacterium tuberculosis–
infected individuals with active disease or latent tuberculosis
showed that latency was consistently associated with increased
NK cell abundance and enhanced cytotoxicity mediated by
CD16 and NK cells (Roy Chowdhury et al., 2018). A direct test of
the contribution of adaptive NK cells to protection frommalaria
through ADCC responses is not feasible in humans. However,
the correlation of PLZF− FcRγ− NK cell abundance among sub-
jects in the cohort with reduced parasite load and reduced
susceptibility to malaria symptoms warrants further inves-
tigations. Translation of our findings to clinical applications
would include protocols to enhance the generation of adaptive
NK cells, which are inherently strong responders to activation
by CD16. In addition, vaccines that elicit IgG1 and IgG3 anti-
bodies to P. falciparum antigens expressed at the surface of
infected RBCs would provide high-affinity ligands for CD16. In
vitro ADCC assays with NK cells are amenable to high-
throughput screens of serum samples. In conclusion, our re-
sults suggest that NK cells play a critical and underappreciated
role in reducing malaria morbidity through ADCC-mediated
clearance of parasites from the blood.
Materials and methods
Human subjects
An ongoing prospective cohort study of naturally acquired ma-
laria immunity in 695 children and adults was initiated in May
2011 in Kalifabougou, Mali, where intense, seasonal transmis-
sion of P. falciparummalaria occurs during the rainy season from
June through December (Doumbo et al., 2014). During the dry
season from January through May, there is little to no malaria
transmission (Portugal et al., 2017b). At least two cross-sectional
collections were conducted during each year of the cohort
study: one at the premalaria season baseline (May) and the
second at the end of the malaria season (December). At each
cross-sectional visit, a complete medical history and physical
examination were performed along with blood collection by
venipuncture and finger stick. Subjects are followed by active
malaria surveillance consisting of scheduled clinic visits with
finger stick blood collection for malaria diagnosis and passive
surveillance consisting of symptom-triggered self-referred vis-
its. Blood smears were performed for malaria diagnosis on any
subject with malaria symptoms. Subjects with any detectable
parasitemia were treated for malaria according to the National
Malaria Control Program guidelines in Mali, which recommend
artemether-lumefantrine for uncomplicated P. falciparum ma-
laria. For this study, malaria susceptibility was defined as at least
one malaria episode (temperature >37.5°C and P. falciparum
parasitemia >2,500 parasites/µl) during a single malaria season,
while malaria resistance was defined as no malaria episode
during the same surveillance period. We used venipuncture
blood samples from 2013 at the premalaria season baseline
(May), during the first febrile malaria episode, 7 d after treat-
ment (convalescence), and at the end of the malaria season
(December). In Mali, blood was collected by venipuncture into
sodium citrate–containing cell preparation tubes (Vacutainer
CPT; Becton Dickinson). Plasma and PBMCs were separated
according to the manufacturer’s instructions. Plasma was frozen
at −80°C. PBMCs were frozen in fetal bovine serum (GIBCO BRL)
containing 7.5% DMSO (Sigma-Aldrich), kept at −80°C for 24 h,
and then stored at −196°C in liquid nitrogen. Samples from Mali
were shipped on dry ice (−78.5°C) over a course of 3 d using a
courier service to Rockville, MD, where PBMC and plasma
samples were again stored in liquid nitrogen vapor phase and
at −80°C, respectively. Dried blood spots were used to determine
the P. falciparum parasite load using real-time PCR amplification
of P. falciparum genes as previously described (Tran et al., 2013).
Sample selection for flow cytometric analysis
From an initial cohort of 695 subjects, we selected PBMCs from
200 subjects based on age, P. falciparum PCR-negative status at
the May 2013 time point, malaria susceptibility, and sample
availability. To reduce batch effects, the order of the subjects in
the Mali cohort for sample analysis for phenotype and function
was randomized, but longitudinal samples from each subject
were analyzed at the same time. After analysis, samples that did
not meet quality control (e.g., poor antibody staining of inter-
nal reference samples, low cell viability) were removed, re-
sulting in a final analysis of samples from 163 subjects (Fig. 1 A
and Fig. S1 A).
Phenotype and functional assays
In a single day, 24–48 PBMC samples including three quality
control PBMC samples described below were thawed. Batches of
six PBMC samples (∼5 million cells per tube) were thawed
rapidly in a 37°C water bath into 15-ml conical tubes. 1 ml of pre-
warmed Roswell Park Memorial Institute-1640 media supple-
mented with 10% fetal bovine serum (RP10) was added, and the
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tubes were swirled by hand. This step was repeated twice. Then
the 15-ml conical tubes were filled with RP10 and centrifuged at
650 × g. Media was aspirated, and the cell pellets were re-
suspended in 4.5 ml of RP10 supplemented with 10 µg/ml gen-
tamycin, and 5 U/ml DNase (Roche). Cells were then “rested”
overnight in a 6-well plate. After 16 h, cells were removed from
the plates and filtered (70 µm) into 5-ml FACS tubes. All cells,
including 721.221 and P815 cell lines, were then counted on a
FACS machine (LSR II) using counting beads (Invitrogen) and
propidium iodide (Sigma-Aldrich) to assess numbers of living
cells. One million PBMCs were used to stain phenotypic mark-
ers. Two samples of half a million PBMCs were mixed separately
with 100,000 721.221 cells or 125,000 P815 cells. The mouse
mastocytoma cell line P815 was first incubated with 2.5 µg/ml
anti-mouse CD32 (clone 2.4G2; Bio-X-Cell). Brefeldin A (Sigma-
Aldrich) was added to a 1 µg/ml final concentration, Monensin
(Sigma-Aldrich) to 2 µM final, and anti-CD107a (BioLegend) at
1:200 to the samples, and cells were incubated for 5 h at 37°C in
5% CO2.
For the phenotype panel, approximately one million PBMCs
were assessed. The primary surface stain was done in PBS for
20 min at room temperature in the dark. Information on an-
tibodies used is found in Fig. S3 F. The secondary stain with
live/dead stain was also done in PBS for 20 min at room
temperature in the dark. Next, cells were washed and then
incubated in 2% methanol-freeelectron microscopy–grade
formaldehyde in PBS at 37°C for 10 min. After fixation, the cells
were washed and centrifuged at 750 × g for 3 min and super-
natants were discarded, and the same washing/centrifugation
was done after each remaining step. Cells were permeabilized
with 0.04% Triton for 7 min at room temperature. Anti-Eat-
2 (rabbit IgG) antibody was then incubated with cells in PBS
with 2% FBS, 2 mM EDTA, and 2% BSA (internal FACS buffer)
for 20 min at room temperature. Cells were then stained with
goat anti-rabbit polyclonal antibody in internal FACS buffer for
20 min at room temperature in the dark. The final internal
stains were with anti-PLZF, anti-FcRγ (FcεRIγ), and anti-Syk in
internal FACS buffer with an additional 10% rabbit serum, to
block any residual anti-rabbit Ig staining, for 2 h at room
temperature in the dark. For the functional panel, cells were
stained in the same way except for the following differences.
The fixation with formaldehyde was done at room tempera-
ture. The final stain for FcRγ chain and IFN-γ was done for
30 min instead of 2 h. The samples were analyzed on a LSR II
cytometer with a violet (405 nm), blue (488 nm), green (562
nm), and red (632 nm) laser set up.
Quality control of stainingwas accomplished by including the
same three PBMC samples in every batch analyzed for phenotye
and function. For each malaria-resistant subject in the cohort,
there were two samples, collected in May and in December. For
each of the malaria-susceptible subjects in the cohort, there
were four samples, collected in May, at the malaria episode, 7 d
after treatment, and in December. Samples from 18 Swedish
subjects that had been analyzed previously in Sweden (Schlums
et al., 2015) were included in this study to evaluate reproduci-
bility. The data generated in this study correlated highly with
previous staining results.
Flow analysis
Statistical analysis of flow data was performed using FlowJo
(TreeStar). For the Boolean analysis of phenotype data, positive
gates for CD2, CD57, NKG2C, NKG2A, PLZF, and FcRγ were de-
termined and all single, double, and triple combinations (232
combinations) of those six markers were entered, and the fre-
quency of resulting populations was tabulated for each subject.
The markers CD8, Eat-2, and Syk were not included in the
Boolean analysis due to the low proportion of CD8+, Eat-2−, and
Syk− NK cells. For the analysis of functional data, the markers
PLZF, Eat-2, and Syk were replaced with markers for cytokine
production and degranulation.
Distribution of NK cell functional responses among NK cell
phenotypic subsets
For stochastic neighbor embedding analyses (van der Maaten
and Hinton, 2008), preprocessing was performed as elsewhere
(Schlums et al., 2015), and the R package Rtsne (https://github.
com/jkrijthe/Rtsne) was used. To visualize how the NK cell
CD107a and IFN-γ responses were distributed over the pheno-
typic subsets, the single-cell Δ response probability was calcu-
lated using the formula
ΔP(response)x  μNNxStim − μNNxCtrl,
where x denotes an individual cell, μNNxStim and μNNxControl
denote the average positivity (CD107a or IFN-γ) among x and the
99 nearest neighbors to x in the stimulated sample that x was
drawn from (ADCC or natural cytotoxicity), or among the 99
nearest neighbors to x in the unstimulated control, respectively.
A cell was defined as positive if the following criterion was met:
FIx > (x˜(FICtrl) + 2MAD(FICtrl)),
where FIx denotes the fluorescence intensity (CD107a or IFN-γ)
of x, x˜ and MAD denote the median and the median absolute
deviation, respectively, and FICtrl is the fluorescence intensity in
the unstimulated control sample from the same individual (pa-
tient or control) that x was drawn from. With this criterion, 6.5
and 2.5% of all the cells in the unstimulated control were defined
as positive for CD107a and IFN-γ, respectively. The 99 nearest
neighbors were identified with the k-nearest neighbor algorithm
(Cover and Hart, 1967) in the seven-dimensional space defined
by CD2, CD8, CD56, CD57, FcRγ, NKG2A, and NKG2C, including
all unstimulated cells or cells from the ADCC or the natural cy-
totoxicity condition, respectively. For this analysis, the k-nearest
neighbor algorithm implementation in the R package FNN was
used (Beygelzimer et al., 2018). After this calculation, the delta
response probability variables for CD107a and IFN-γ were dis-
played on a t-SNE field generated with CD2, CD8, CD56, CD57,
FcRγ, NKG2A, and NKG2C as input dimensions.
Activation of NK cells by P. falciparum–infected RBCs
RBCs infected with P. falciparum 3D7 strain and enriched for
trophozoite stage were used to assess natural cytotoxicity and
ADCC responses in cultures with PBMC. ADCC was tested with
infected RBCs and a pool of plasma from malaria-immune Mali
adults (Arora et al., 2018). Plasma fromhealthy,malaria-unexposed
US donors was used as control. The ratio of PBMC to RBC target
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was 1:1, totaling 1 million cells per well. Brefeldin A, monensin, and
mAb to CD107a were added as described in the assay with P815
cells, and sampleswere incubated for 5 h at 37°C in RP10 in 5%CO2.
Testing for CMV and EBV
The presence of IgG for EBV and CMV antigens in plasma
samples was analyzed using Liaison assays on a DiaSorin Liaison
XL analyzer according to the manufacturer’s instructions.
Qualitative determination of specific IgG to human CMV anti-
gens, and EBV antigens EBNA1 or VCA, was by indirect chemi-
luminescence immunoassay. Of the two EBV antigens tested,
EBNA1 is expressed during latency, and VCA is typically ex-
pressed during the lytic cycle (Taylor et al., 2015). The main
components of the test were magnetic particles coated with the
viral proteins of interest and a conjugate of mAb to human IgG
linked to an isoluminol derivative. During a first incubation,
antibodies added to calibrators, samples, or controls bound to
the magnetic particles. During a second incubation, the antibody
conjugate reacted with viral specific IgG that was already bound
to the magnetic particle. After each incubation, unbound ma-
terial was removed with a wash cycle. Subsequently, the starter
reagents were added, and a flash chemiluminescence reaction
was induced. The light signal, and subsequent amount of
isoluminol–antibody conjugate, was measured by a photomul-
tiplier as relative light units and was indicative of the presence
of viral specific IgG antibodies present in calibrators, samples or
controls. Approximately 140 µl of plasma was used from each
subject. Positive signals were determined using the manu-
facturer’s recommendations of relative light units.
Statistical analysis
Statistical analysis was performed using Prism 7 (Graphpad
software), Excel version 16.14.1 (Microsoft), and R version 3.4.4.
As noted in the figures, one-way ANOVA analysis was done for
most graphs where means were shown and post hoc P value
multiple comparison tests were determined using Sidak’s test.
For Kaplan–Meier analysis, the P values given were from a log
rank Mantel–Cox test. Linear and nonlinear regression analysis
and R2 goodness-of-fit calculations were performed with Prism.
The P value of the correlation of the two variables was deter-
mined using Pearson correlation analysis in Prism. To determine
the relationship between specific NK subsets and parasite den-
sity, multiple linear regression was performed using log (para-
sites per microliter) as the dependent variable and the age (in
years) and NK subset frequency (either FcRγ− or PLZF− NK cells
in separate models) as independent covariates.
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Online supplemental material
Fig. S1 provides information on subjects who participated in the
study; a comparison of NK phenotypic subsets between Malian
and Swedish subjects; serological data on EBV and CMV, and
their correlation with NK phenotypic markers; and Boolean
distribution of NKG2C, CD57, and FcRγ markers on NK cells in
Malian subjects. Fig. S2 lists NK cell subsets most enriched in
resistant subjects; and shows the relationship of parasite load
with age, and a multiple linear regression analysis of the asso-
ciation of age, FcRγ− NK, and PLZF− NK cells with parasite load.
Fig. S3 shows flow cytometry analysis of CD16 expression on NK
cells from the study participants and its relationship to malaria
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